Global healthcare company Abbott (NYSE:ABT) announced on Monday the release of Libre Assist, a new feature within the Libre app.

Libre Assist is designed to help people living with diabetes in the US better understand how the foods they eat affect their glucose levels. Unlike traditional food logging apps that only give feedback after a meal is logged, Libre Assist is designed to help people make informed mealtime decisions before they eat.

Using generative artificial intelligence (AI), the feature illustrates the potential glucose impact of a food choice with a color-coded rating system -- green for minor, yellow for moderate, and orange for major.

Abbott is launching the new technology during CES 2026 in Las Vegas.